Stevanato Group S.p.A (STVN) Cash from Discontinued Operations (2020 - 2023)
Stevanato Group S.p.A (STVN) posted quarterly Cash from Discontinued Operations of 40399094.94 for Q2 2023, down 10.28% year-over-year from 45029792.24 in Q2 2022, and down 10.28% quarter-over-quarter from 45029792.24 in Q2 2022.
Stevanato Group S.p.A (STVN) Cash from Discontinued Operations (2020 - 2023) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Cash from Discontinued Operations for 4 consecutive years, with 40399094.94 the latest figure, recorded in Q2 2023.
- In Q2 2023, Cash from Discontinued Operations fell 10.28% year-over-year to 40399094.94; the TTM figure through Jun 2023 stood at 169914120.95 (down 12.72% YoY), while the FY2021 annual figure was 157746845.05, down 15.03% from the prior year.
- Cash from Discontinued Operations declined to 40399094.94 in Q2 2023 per STVN's latest filing, from 45029792.24 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 72610451.82 in Q4 2020 and bottomed at 21109243.07 in Q3 2021.
- Historically, Cash from Discontinued Operations has averaged 53195628.51 across 4 years, with a median of 58944685.28 in 2020.
- On a YoY basis, Cash from Discontinued Operations climbed as much as 9.74% in 2021 and fell as far as 63.93% in 2021.
- Stevanato Group S.p.A's Cash from Discontinued Operations stood at 72610451.82 in 2020, then dropped by 12.72% to 63375990.69 in 2021, then dropped by 28.95% to 45029792.24 in 2022, then slipped by 10.28% to 40399094.94 in 2023.
- Business Quant data shows STVN's Cash from Discontinued Operations at 40399094.94 in Q2 2023, 45029792.24 in Q2 2022, and 63375990.69 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -125.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -12.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 40.40 Mn |
| Jun 30, 2023 | 40.40 Mn |
| Jun 30, 2022 | 45.03 Mn |
| Jun 30, 2022 | 45.03 Mn |
| Dec 31, 2021 | 63.38 Mn |
| Dec 31, 2021 | 63.38 Mn |
| Sep 30, 2021 | 21.11 Mn |
| Sep 30, 2021 | 21.11 Mn |
| Jun 30, 2021 | 65.15 Mn |
| Jun 30, 2021 | 65.15 Mn |
| Dec 31, 2020 | 72.61 Mn |
| Dec 31, 2020 | 72.61 Mn |
| Sep 30, 2020 | 58.52 Mn |
| Sep 30, 2020 | 58.52 Mn |
| Jun 30, 2020 | 59.37 Mn |
| Jun 30, 2020 | 59.37 Mn |